Schering Licenses Inpharmatica's Kinase SARfari Knowledge Base | GenomeWeb
NEW YORK (GenomeWeb News) — Inpharmatica today said that Schering AG has obtained a multi-year, multi-user license to its Kinase SARfari knowledge base.
The product covers the biology and chemistry of the major group of successful targets in drug discovery, and Schering will use it as part of its drug-discovery process in the field of protein kinases, Inpharmatica said.
Financial terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.